MaureenMOkamMDMPH

PubMed

• 2 citations
  A systematic literature review and meta-analysis of the incidence of serious or severe hypersensitivity reactions after administration of ferric derisomaltose or ferri...
  Nicholas A Kennedy, Maureen M Achebe, Patrick Biggar, Johannes Pöhlmann, Richard F Pollock> ;International Journal of Clinical Pharmacy. 2023 Jun 1
• 33 citations
  Iron Supplementation, Response in Iron-Deficiency Anemia: Analysis of Five Trials
  Maureen Okam, Todd A. Koch, Minh-Ha Tran> ;The American Journal of Medicine. 2017 Aug 1
• 20 citations
  Iron deficiency anemia treatment response to oral iron therapy: a pooled analysis of five randomized controlled trials
  Maureen Okam, Todd A. Koch, Minh-Ha Tran> ;Haematologica. 2016 Jan 1
• 19 citations
  Phase 1/2 trial of vorinostat in patients with sickle cell disease who have not benefitted from hydroxyurea
  Maureen Okam, Erica B. Esrick, Elyse Mandell, Federico Campigotto, Donna Neuberg, Benjamin L. Ebert> ;Blood. 2015 Jun 4
• 25 citations
  National trends in hospitalizations for sickle cell disease in the United States following the FDA approval of hydroxyurea, 1998-2008.
  Maureen Okam, Shimon Shaykevich, Benjamin L. Ebert, Alan M. Zaslavsky, John Z. Ayanian> ;Medical Care. 2014 Jul 1
• 71 citations
  Sickle cell vaso-occlusion causes activation of iNKT cells that is decreased by the adenosine A2A receptor agonist regadenoson.
  Joshua J. Field, Gene Lin, Maureen Okam, Elaine M. Majerus, Jeffrey R. Keefer, Onyinye Onyekwere, Ainsley Ross, Federico Campigotto, Donna Neuberg, Joel Linden, David ...> ;Blood. 2013 Apr 25
• 40 citations
  Comparative rates of adverse events with different formulations of intravenous iron.
  Maureen Okam, Elyse Mandell, Nathanael D. Hevelone, Rachel Wentz, Ainsley Ross, Gregory A. Abel> ;American Journal of Hematology. 2012 Nov 1
• 8 citations
  Novel approaches to the treatment of sickle cell disease: the potential of histone deacetylase inhibitors
  Maureen Okam, Benjamin L. Ebert> ;Expert Review of Hematology. 2012 Jun 1
• 38 citations
  Refining the value of secretory phospholipase A2 as a predictor of acute chest syndrome in sickle cell disease: results of a feasibility study (PROACTIVE)
  Lori Styles, Carrie G. Wager, Richard J. Labotka, Kim Smith-Whitley, Alexis A. Thompson, Peter A. Lane, Lillian McMahon, Robin E Miller, Susan D. Roseff, Rathi V. Iyer...> ;British Journal of Haematology. 2012 Jun 1
• 5 citations
  Sickle cell disease (SCD), iNKT cells, and regadenoson infusion.
  David G. Nathan, Joshua J. Field, Gene Lin, Donna Neuberg, Elaine M. Majerus, Onyinye Onyekwere, Jeffrey R. Keefer, Maureen Okam, Ainsley Ross, Joel Linden> ;Transactions of the American Clinical and Climatological Association. 2012 Jan 1
• 148 citations
  Nitric Oxide for Inhalation in the Acute Treatment of Sickle Cell Pain Crisis: A Randomized Controlled Trial
  Mark T. Gladwin, Gregory J. Kato, Debra L. Weiner, Onyinye Onyekwere, Carlton Dampier, Lewis L. Hsu, R. Ward Hagar, Thomas H. Howard, Rachelle Nuss, Maureen Okam, Caro...> ;JAMA. 2011 Mar 2
• 6 citations
  NK-cell and B-cell deficiency with a thymic mass.
  Samuel Ng, Christopher H. Fanta, Maureen Okam, Ami S. Bhatt> ;The New England Journal of Medicine. 2011 Feb 9
• 330 citations
  The risks and benefits of long-term use of hydroxyurea in sickle cell anemia: A 17.5 year follow-up
  Martin H. Steinberg, William F. McCarthy, Oswaldo Castro, Samir K. Ballas, F. Danny Armstrong, Wally R. Smith, Kenneth I. Ataga, Paul Swerdlow, Abdullah Kutlar, Laura ...> ;American Journal of Hematology. 2010 Jun 1
• 2 citations
  Spontaneous pneumothorax as the first manifestation of lymphoma: a rare presentation and the importance of diagnostic biopsy.
  Maureen Okam, Mohammad M. Alsolaiman, Alan Brau, Mariette Austin, Matthew Plymyer> ;Southern Medical Journal. 2003 Jan 1
• Join now to see all